Activity ID
12899Expires
November 30, 2024Format Type
LiveCME Credit
1Fee
$0CME Provider: Clinical Care Options, LLC
Description of CME Course
This activity is intended for physicians, physician associates, nurse practitioners, registered nurses, pharmacists, social workers, and psychologists engaged in the care of patients with psychiatric illness.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Psychiatry and Neurology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
o Recognize the importance of managing diabetes and obesity in patients with serious mental illness
o Compare and contrast the physiologic roles of the incretin hormones GLP-1 and GIP
o List the FDA-approved indications for GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists
o Critically assess the therapeutic benefits and potential risks of
o GLP-1 receptor agonists and GLP-1/GIP receptor agonists in
o mental health patients
Keywords
GLP-1 Agonist, Diabetes, Obesity, Mental Health
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
Practice Setting
Academic Medicine, Inpatient, Outpatient, Rural, Urban, VA/Military
